HOUSTON, Sept. 30, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that Nutex Health hospitals have won multiple community-driven awards and accolades in the third quarter of 2024, reflecting the staff's commitment to excellence.
We believe that the main reason our hospitals are recognized for superior healthcare delivery is our organization's primary focus on patient care. Patients always come first, and our entire organization and its processes revolve around delivering the best patient care possible.
Each award was voted on by their respective communities, demonstrating patient satisfaction and unparalleled service.
Facility | Award | Month | Publication |
Tulsa ER & | "Faces of the 918"
| July | Tulsa People |
Oklahoma ER & | "Faces of Emergency Care"
| August | 405 Magazine |
Albuquerque | "Best Places to Work" | August | Albuquerque |
New Braunfels | The Best of New Braunfels, "Best Emergency Care" | August | Herald- |
Cabot | All six of the hospital's
| August | AY Magazine |
The Colony ER | CNO, Russell Kaiser, RN, | September | CIO Views |
Texarkana | "Best ER" | September | The Texarkana |
Tulsa ER & | Faces of Oklahoma Awards, "Face of Emergency | September | Oklahoma |
Tucson ER & | Voted a "Favorite" for
| September | Arizona Daily |
Additional noteworthy corporate Q3 highlights include:
"Congratulations to our entire team for these well-deserved accolades and recognitions as we continue our mission of providing exemplary care to our communities," stated Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health.
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in 10 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). We provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and in the Quarterly Report on Form 10-Q for the period ended June 30, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
Last Trade: | US$30.28 |
Daily Change: | -1.49 -4.69 |
Daily Volume: | 7,696 |
Market Cap: | US$164.720M |
November 07, 2024 August 08, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB